Improvement of the Relation between Existing Techniques of Product and Food Protection and Drugs Safety Management

DOI: 10.4236/jss.2016.411003, PP. 43-52

Keywords: Safety Management, Product Authenticity, Counterfeit, Supply Chain Security

Full-Text   Cite this paper   Add to My Lib

Abstract:

The goal of this paper is to assess the existing methods of food and drugs safety man-agement from the standpoint of product packaging and labeling. Several methods of safety management have been introduced in order to protect both supply chains and consumers from fake commodities, yet their effectiveness is a relevant question since counterfeiters keep up with the development and implementation of advanced protec-tive means. Since verifying drugs’ authenticity is a crucial issue nowadays and fake commodities represent significant economic and societal challenges, a new set of counter-measures must be put in place to address the advancing growth of the counterfeit threat. A conceptual model will be used to assess the existing problems of food and drug safety, and practical implications will be derived out of the real life situations that occurred with pharmaceutical manufactures. Analysis of the existing ways of how essential commodities are protected and propositions on how these ways could be upgraded will improve the understanding of food and drugs safety management. The improved system of food and drug safety management implies a set of actions that have to be undertaken in order to form a solid, unified system and thus provide complete assurances of a product’s safety. Not only does the security of supply chains and product traceability systems need improvement, but also existing public policies regarding compulsory food and pharmaceutical certifications need to be reviewed.

References

[1]	Fenoff, R. and Wilson, J. (2009) Africa’s Counterfeit Pharmaceutical Epidemic. Anti-Coun- terfeiting and Product Protection Program. A-CAPPP Paper Series.
[2]	WHO (2016) Substandard, Spurious, Falsely Labelled, Falsified and Counterfeit (SSFFC) Medical Products. Fact Sheet.
[3]	UNICRI (2014) Counterfeiting as an Activity Managed by Transnational Organized Crime and the Possible Re-Use of Seized Assets for the Promotion of Intellectual Property and Economic Growth. Ministry of Economic Development. Directorate-General for the Fight against Counterfeiting—Italian Patent and Trademark Office.
[4]	European Commission (2014) Report on EU Customs Enforcement of Intellectual Property Rights, Results of EU Border 2013. Publications Office of the European Union, 2014.
[5]	Interpol (2014) Against Oganized Crime. Interpol Trafficking and Counterfeiting Casebook 2014.
[6]	OECD (2008) The Economic Impact of Counterfeiting and Piracy. Organisation for Economic Co-Operation and Development. 65-90, 152. https://www.oecd.org/sti/38707619.pdf
[7]	Jackson, G., Patel, S. and Khan, S. (2011) Assessing the Problem of Counterfeit Medications in the United Kingdom. International Journal of Clinical Practice, 66, 241-250. http://dx.doi.org/10.1111/j.1742-1241.2011.02826.x
[8]	AIFA (2016) L’Agenzia Italianadel Farmaco. http://www.agenziafarmaco.gov.it/
[9]	Bronshtein, D. (2008) Counterfeit Pharmaceuticals in China: Could Changes Bring Stronger Pro-tection for Intellectual Property Rights and Human Health? Pacific Rim Law & Policy Journal Association.
[10]	Bate, R. (2008) The Deadly World of Fake Drugs. Foreign Policy, No. 168 (Sep-Oct 2008), 56-62, 64-65. Washington Post. Newsweek Interactive, LLC.
[11]	WHO (2011) One-Third of Antimalarial Medicines Tested in Six African Countries Fail to Meet International Quality Standards. Information Note: 25 February 2011.
[12]	Alexandrova, L. (2014) Russia Needs Effective Remedy Against fake Drugs. Remedium.
[13]	UNICRI (2012) Counterfeit Medicines and Organised Crime. United Nations Interregional Crime and Justice Research Institute.
[14]	Interpol (2015) INTERPOL-Coordinated Operation Strikes at Organized Crime with Seizure of 20 million Illicit Medicines. Largest ever Operation Pangea VIII Targets Online Sales of Medicines and Medical Devices.
[15]	Europol (2015) Situation Report on Counterfeiting in the European Union. A Joint Project between Europol and the Office for Harmonization in the Internal Market.
[16]	OECD (2007) The Economic Impact of Counterfeiting and Piracy. Executive Summary.
[17]	Probst, L., Frideres, L. and Pedersen, B. (2015) Traceability across the Value Chain New Anti-Counterfeiting Methods. European Union: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs. Directorate “Industrial Property, Innovation & Standards”, Unit J.3 “Innovation Policy for Growth”. Business Innovation Observatory Contract No 190/PP/ENT/CIP/12/C/N03C01.
[18]	Fozley, M. (2005) Combating Counterfeit Drugs: A Concept Paper Effective International Colla-boration. World Health Organisation. Health Technology and Pharmaceuticals.
[19]	Lybecker, K.M. (2007) Combatting Counterfeit Pharmaceuticals in Developing Nations. Managerial and Decision Economics, 28, Economic and Policy Issues in the Pharmaceutical Industry (Jun-Aug 2007). http://dx.doi.org/10.1002/mde.1359
[20]	Jenkins, J., Associates & WP6 Partners (2007) Pharma Traceability Pilot Problem Analysis. BRIDGE—Building Radio Frequency IDentification Solutions for the Global Environment. Domino, GS1 UK, Melior Solutions Ltd, VeriSign Inc.
[21]	Koh, R., Schuster, E., Chackrabarti I. and Bellman, A. (2003) Securing the Pharmaceutical Supply Chain White Paper. Auto-id Center. Massachusetts Institute of Technology.
[22]	McCathie, L. (2004) The Advantages and Disadvantages of Barcodes and Radio Frequency Identification in Supply Chain Management. University of Wollongong Thesis Collections, University of Wollongong Research Online.

Full-Text